Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical cash
Cash and short-term investments held at the end of each period.
Aethlon Medical's cash was $4.93M at Jun 30, 2026. For fiscal 2026 it was $5.03M, down 10.2% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $17.16M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $5.03M | -10.2% |
| FY2025 | Mar 31, 2025 | $5.60M | +1.3% |
| FY2024 | Mar 31, 2024 | $5.53M | +2111.8% |
| FY2023 | Mar 31, 2023 | $250.00K | -98.5% |
| FY2022 | Mar 31, 2022 | $17.16M | +73.2% |
| FY2021 | Mar 31, 2021 | $9.91M | +3.2% |
| FY2020 | Mar 31, 2020 | $9.60M | +150.9% |
| FY2019 | Mar 31, 2019 | $3.83M | -45.1% |
| FY2018 | Mar 31, 2018 | $6.97M | +347.1% |
| FY2017 | Mar 31, 2017 | $1.56M | -26.6% |
| FY2016 | Mar 31, 2016 | $2.12M | +148.2% |
| FY2015 | Mar 31, 2015 | $855.60K | -31.6% |
| FY2014 | Mar 31, 2014 | $1.25M | +898.0% |
| FY2013 | Mar 31, 2013 | $125.27K | -12.9% |
| FY2012 | Mar 31, 2012 | $143.91K | +816.4% |
| FY2011 | Mar 31, 2011 | $15.70K | -76.9% |
| FY2010 | Mar 31, 2010 | $67.95K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $4.93M | -11.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $5.03M | +4.2% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $6.96M | +1.4% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $3.77M | -58.5% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $5.60M | +1.3% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $4.83M | -39.5% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $6.86M | -32.6% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $9.07M | -29.7% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $5.53M | +2111.8% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $7.97M | -54.4% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $10.18M | -48.1% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $12.90M | -13.6% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $250.00K | -98.5% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $17.50M | -14.2% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $19.60M | -15.6% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $14.92M | -40.7% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $17.16M | +73.2% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $20.39M | +68.1% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $23.22M | +60.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $25.17M | +60.1% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $9.91M | +3.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $12.13M | +198.9% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $14.47M | +1742.2% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $15.72M | +530.8% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $9.60M | +150.9% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $4.06M | -15.9% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $785.66K | -84.5% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $2.49M | -59.3% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $3.83M | -45.1% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $4.82M | -14.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $5.08M | +452.0% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $6.12M | +1771.3% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $6.97M | +347.1% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $5.61M | +792.6% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $920.07K | +65.4% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $327.21K | -74.7% |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $1.56M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $628.62K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $556.35K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | $1.29M | – |
See a number that looks wrong?